This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Toxinvent Ou. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Olga Tsubrik: Innovator in Cancer Treatment
Introduction
Olga Tsubrik is a prominent inventor based in Tartu, Estonia. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel anthracycline derivatives. Her work focuses on improving the efficacy of antibody-drug conjugates (ADCs) for cancer therapy.
Latest Patents
Olga Tsubrik holds 1 patent for her invention titled "Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment." This patent relates to the development of novel anthracycline derivatives that include two oxazolidine cycles. The invention also encompasses the preparation of these derivatives and their application in ADCs for the prevention and treatment of cancer.
Career Highlights
Throughout her career, Olga has worked with various companies, including Toxinvent OÜ and Tbd-Biodiscovery. Her expertise in the field has allowed her to make substantial advancements in cancer treatment methodologies.
Collaborations
Olga has collaborated with notable professionals in her field, including Uno Mäeorg and Ivan Ogibalov. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Olga Tsubrik is a trailblazer in the realm of cancer treatment, with her innovative approaches and patented inventions paving the way for future advancements in medical therapies. Her dedication to research and collaboration continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile